| SC 13D/A | 2023-11-22 | Samsara BioCapital, L.P. | CHINOOK THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13D | 2023-08-11 | Farallon Capital Partners, L.P. | CHINOOK THERAPEUTICS, INC. | 1,244,600 | 1.7% | EDGAR |
| SC 13G/A | 2023-08-01 | BAILLIE GIFFORD & CO | CHINOOK THERAPEUTICS, INC. | 844,684 | 2.0% | EDGAR |
| SC 13D/A | 2023-03-10 | Versant Venture Capital VII, L.P. | CHINOOK THERAPEUTICS, INC. | 2,105,107 | 3.2% | EDGAR |
| SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | CHINOOK THERAPEUTICS, INC. | 1,267,660 | 2.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | CHINOOK THERAPEUTICS, INC. | 3,000,000 | 4.7% | EDGAR |
| SC 13G/A | 2023-02-14 | Frazier Life Sciences Public Fund, L.P. | CHINOOK THERAPEUTICS, INC. | 3,128,211 | 4.9% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | CHINOOK THERAPEUTICS, INC. | 3,954,741 | 6.2% | EDGAR |
| SC 13D/A | 2022-12-28 | Versant Venture Capital VII, L.P. | CHINOOK THERAPEUTICS, INC. | 2,345,107 | 3.7% | EDGAR |
| SC 13D/A | 2022-08-22 | Versant Venture Capital VII, L.P. | CHINOOK THERAPEUTICS, INC. | 2,913,070 | 4.6% | EDGAR |
| SC 13G | 2022-06-07 | Point72 Asset Management, L.P. | CHINOOK THERAPEUTICS, INC. | 3,047,732 | 5.0% | EDGAR |
| SC 13D | 2022-06-01 | Samsara BioCapital, L.P. | CHINOOK THERAPEUTICS, INC. | 5,161,888 | 8.4% | EDGAR |
| SC 13G | 2022-04-29 | Frazier Life Sciences Public Fund, L.P. | CHINOOK THERAPEUTICS, INC. | 1,870,270 | 3.4% | EDGAR |
| SC 13D/A | 2022-04-13 | Versant Venture Capital VII, L.P. | CHINOOK THERAPEUTICS, INC. | 2,913,070 | 5.3% | EDGAR |
| SC 13D/A | 2022-02-22 | Morningside Venture (VI) Investments Ltd | CHINOOK THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-16 | Deep Track Capital, LP | CHINOOK THERAPEUTICS, INC. | 2,752,070 | 5.0% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | CHINOOK THERAPEUTICS, INC. | 2,987,931 | 5.6% | EDGAR |
| SC 13G/A | 2022-01-21 | ATP Life Science Ventures, L.P. | CHINOOK THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-01-13 | Versant Venture Capital VII, L.P. | CHINOOK THERAPEUTICS, INC. | 3,623,023 | 6.7% | EDGAR |
| SC 13D/A | 2021-09-07 | Versant Venture Capital VII, L.P. | CHINOOK THERAPEUTICS, INC. | 4,223,023 | 9.4% | EDGAR |